Collect. Czech. Chem. Commun. 2006, 71, 912-928
https://doi.org/10.1135/cccc20060912

Nucleoside Prodrugs of A3 Adenosine Receptor Agonists and Antagonists

Pedro Besadaa, Liaman K. Mamedovaa, Krishnan K. Palaniappana, Zhan-Guo Gaoa, Bhalchandra V. Joshia, Lak Shin Jeongb, Mortimer M. Civanc and Kenneth A. Jacobsona,*

a Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, U.S.A.
b Laboratory of Medicinal Chemistry, College of Pharmacy, Ewha Womans University, Seoul 120-750, Korea
c Departments of Physiology and Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.

References

1. Jacobson K. A., Gao Z. G.: Nat. Rev. Drug Discovery 2006, 5, 247. <https://doi.org/10.1038/nrd1983>
2. Joshi B. V., Jacobson K. A.: Curr. Top. Med. Chem. 2005, 5, 1275. <https://doi.org/10.2174/156802605774463079>
3. Müller C.: Curr. Top. Med. Chem. 2003, 3, 445. <https://doi.org/10.2174/1568026033392174>
4. Baraldi P. G., Fruttarolo F., Tabrizi M. A., Romagnoli R., Preti D., Carrion M. D., Iaconinoto A., Borea P. A.: Expert Opin. Ther. Patents 2005, 15, 1507. <https://doi.org/10.1517/13543776.15.11.1507>
5. Moro S., Gao Z. G., Jacobson K. A., Spalluto G.: Med. Res. Rev. 2006, 26, 131. <https://doi.org/10.1002/med.20048>
6. von Lubitz D. K. J. E., Lin R. C.-S., Popik P., Carter M. F., Jacobson K. A.: Eur. J. Pharmacol. 1994, 263, 59. <https://doi.org/10.1016/0014-2999(94)90523-1>
7. Pugliese A. M., Coppi E., Spalluto G., Corradetti R., Pedata F.: Br. J. Pharmacol. 2006, 147, 524. <https://doi.org/10.1038/sj.bjp.0706646>
8. Liang B. T., Jacobson K. A.: Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6995. <https://doi.org/10.1073/pnas.95.12.6995>
9. Headrick J. P., Peart J.: Vascul. Pharmacol. 2005, 42, 271. <https://doi.org/10.1016/j.vph.2005.02.009>
10. Jacobson K. A., Gao Z. G., Tchilibon S., Duong H. T., Joshi B. V., Sonin D., Liang B. T.: J. Med. Chem. 2005, 48, 8103. <https://doi.org/10.1021/jm050726b>
11. Bar-Yehuda S., Madi L., Silberman D., Gery S., Shkapenuk M., Fishman P.: Neoplasia 2005, 7, 85. <https://doi.org/10.1593/neo.04364>
12. van Troostenburg A. R., Clark E. V., Carey W. D., Warrington S. J., Kerns W. D., Cohn I., Silverman M. H., Bar-Yehuda S., Fong K. L., Fishman P.: Int. J. Clin. Pharmacol. Ther. 2004, 42, 534. <https://doi.org/10.5414/CPP42534>
13. Baharav E., Bar-Yehuda S., Madi L., Silberman D., Rath-Wolfson L., Halpren M., Ochaion A., Weinberger A., Fishman P.: J. Rheumatol. 2005, 32, 469.
14. Avila M. Y., Stone R. A., Civan M. M.: Br. J. Pharmacol. 2001, 134, 241. <https://doi.org/10.1038/sj.bjp.0704267>
15. Okamura T., Kurogi Y., Nishikawa H., Hashimoto K., Fujiwara H., Nagao Y.: J. Med. Chem. 2002, 45, 3703. <https://doi.org/10.1021/jm010570p>
16. Yang H., Avila M. Y., Peterson-Yantorno K., Coca-Prados M., Stone R. A., Jacobson K. A., Civan M. M.: Curr. Eye Res. 2005, 30, 747. <https://doi.org/10.1080/02713680590953147>
17. Gao Z. G., Joshi B. V., Klutz A., Kim S. K., Lee H. W., Kim H. O., Jeong L. S., Jacobson K. A.: Bioorg. Med. Chem. Lett. 2006, 16, 596. <https://doi.org/10.1016/j.bmcl.2005.10.054>
18. Jong A., Huang S. H.: Curr. Drug Targets – Infect. Disorders 2005, 5, 65. <https://doi.org/10.2174/1568005053174672>
19. Maillard M., Nikodijevic O., LaNoue K. F., Berkich D. A., Ji X.-D., Bartus R., Jacobson K. A.: J. Pharm. Sci. 1994, 83, 46. <https://doi.org/10.1002/jps.2600830112>
20. Dalpiaz A., Scatturin A., Menegatti E., Bortolotti F., Pavan B., Biondi C., Durini E., Manfredini S.: Pharm. Res. 2001, 18, 531. <https://doi.org/10.1023/A:1011018730459>
21. Leo E., Contado C., Bortolotti F., Pavan B., Scatturin A., Tosi G., Manfredini S., Angusti A., Dalpiaz A.: Int. J. Pharm. 2006, 307, 103. <https://doi.org/10.1016/j.ijpharm.2005.09.031>
22. Jeong L. S., Lee H. W., Jacobson K. A., Kim H. O., Shin D. H., Lee J. A., Gao Z. G., Lu C., Duong H. T., Gunaga P., Lee S. K., Jin D. Z., Chun M. W., Moon H. R.: J. Med. Chem. 2006, 49, 273. <https://doi.org/10.1021/jm050595e>
23. Tchilibon S., Kim S. K., Gao Z. G., Harris B. A., Blaustein J., Gross A. S., Melman N., Jacobson K. A.: Biooorg. Med. Chem. 2004, 12, 2021. <https://doi.org/10.1016/j.bmc.2004.02.037>
24. Mathot R. A. A., Appel S., van Schaick E. A., Soudijn W., IJzerman A. P., Danhof M.: J. Chromatogr. 1993, 620, 113. <https://doi.org/10.1016/0378-4347(93)80058-C>
25. Kehraus S., Gorzalka S., Hallmen C., Iqbal J., Müller C. E., Wright A. D., Wiese M., Konig G. M.: J. Med. Chem. 2004, 47, 2243. <https://doi.org/10.1021/jm031092g>
26. Bamat M. K., von Borstel R. W.: U.S. 5470838, 1995.
27. De Clercq E., Field H. J.: Br. J. Pharmacol. 2006, 147, 1. <https://doi.org/10.1038/sj.bjp.0706446>
28. Zidek Z., Franková D., Holý A., Boubelík M., Draber P.: Biochem. Pharmacol. 1997, 54, 855. <https://doi.org/10.1016/S0006-2952(97)00228-1>
29. Pavan B., IJzerman A.: Biochem. Pharmacol. 1998, 56, 1625. <https://doi.org/10.1016/S0006-2952(98)00270-6>